MedPath
NMPA Approval

Azithromycin for Suspension

国药准字H20244232

June 28, 2024

Drug Information

阿奇霉素干混悬剂

口服混悬剂

0.1g(以C₃₈H₇₂N₂O₁₂计)

化学药品

June 28, 2024

Company Information

Applicant Company

成都市温江区成都海峡两岸科技产业开发园区

Manufacturing Company

四川省成都市成都海峡两岸科技园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿奇霉素干混悬剂 - NMPA 批准文号 | MedPath